Ayasdi Launches Ayasdi Cure Application to Catalyze Next Generation Precision Medicine
Ayasdi Announces 400% Performance Improvement for Real-Time
Analysis of Life Science Data with Intel Xeon Processor-Based Platforms;
CLC bio, QIAGEN Company, and Ayasdi Partner to Help Scientists Make
Discoveries in Genetic Sequencing Data
MENLO PARK, CA and BOSTON, MA, Apr 29, 2014 (Marketwired via COMTEX) -- -- Bio-IT -- Today at Bio-IT World Conference and Expo 2014, Ayasdi ( www.ayasdi.com ) launched Ayasdi Cure, a new application designed to help pharmaceutical and biotech companies accelerate the drug discovery process by 50% in the era of precision medicine. Ayasdi Cure runs on Ayasdi's award-winning machine learning platform, which merges hundreds of algorithms with Topological Data Analysis (TDA) and obviates the need for queries or coding.